Evidence map›Paper›PMID 42319571›Full record

ArticleVirus genes2026

Whole genome sequencing of measles viruses: the benefit for outbreak investigation, The Netherlands, 2013-2014.

Rogier Bodewes, Cyril Maissan, Linda van de Nes-Reijnen, Marjan Boter, Susanne C van den Boom, Florian Zwagemaker, Susan Hahné, Tom Woudenberg, Wilhelmina L M Ruijs, Marion P G Koopmans and 5 more

Abstract read
In one paragraph

Article in Virus genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rogier BodewesCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. rogier.bodewes@rivm.nl.ORCID https://orcid.org/0000-0002-0689-7889
Cyril MaissanCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Linda van de Nes-ReijnenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Marjan BoterDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Susanne C van den BoomDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Florian ZwagemakerCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Susan HahnéCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Tom WoudenbergCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Wilhelmina L M RuijsCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Marion P G KoopmansDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Chantal B E M ReuskenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Rory D de VriesDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Richard MolenkampDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Rik L de SwartDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
B Oude MunninkDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Funding

ZonMw 10150511910052
6 · The paper itself

Abstract

Measles is a highly contagious infectious disease and remains a major cause of global morbidity and mortality. Molecular surveillance of measles virus (MV) is used for tracing transmission chains, by, for instance, distinguishing between repeated introductions and endemic circulation. WHO guidelines used in the global measles surveillance network recommend sequencing of a 450-nucleotide region at the C-terminal end of the N-gene (N450). Given the limited genetic variability of MV, whole-genome sequencing would increase the resolution and provide a more detailed molecular surveillance of circulating MV. In this study, we describe an amplicon-based nanopore sequencing protocol for generating near complete whole MV genome sequences (nWGS; 15,813 nucleotides). We applied this protocol to samples collected during an epidemic of measles in the Netherlands in 2013-2014, involving an estimated 30,000 cases, to quantify the sequence variation of nWGS during this epidemic. While this was considered an epidemic with very limited sequence variation based on analysis of the N450 region, different molecular clusters were identified by phylogenetic analysis of nWGS genomes. Notably, the number of single nucleotide variants (SNVs) between viruses detected during the early and late phase of the epidemic varied among molecular clusters. Four epidemiological clusters could be identified in the beginning of the epidemic, of which 2 were supported by molecular data. Analysis of nWGS genomes suggested that the epidemic started with either a single unnoticed introduction into the Netherlands and a few unnoticed generations or with at least 2 introductions at the same time, the latter option is supported by epidemiological data. These results can aid in interpreting MV sequence variation during transmission chains, outbreaks and epidemics in countries or regions approaching measles elimination.

Indexed as

Genome, ViralMeaslesMeasles virusWhole Genome SequencingDisease OutbreaksGenetic VariationHumansNetherlandsPhylogenyGenetic variationMeasles virusMolecular surveillanceSequencing

Identifiers

PMID42319571
PMCPMC13461698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.